Gregory M. Cresswell

587 total citations
17 papers, 348 citations indexed

About

Gregory M. Cresswell is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Gregory M. Cresswell has authored 17 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Gregory M. Cresswell's work include Immune cells in cancer (6 papers), Immune Cell Function and Interaction (4 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Gregory M. Cresswell is often cited by papers focused on Immune cells in cancer (6 papers), Immune Cell Function and Interaction (4 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Gregory M. Cresswell collaborates with scholars based in United States, South Korea and Jordan. Gregory M. Cresswell's co-authors include Timothy L. Ratliff, Yoon Yeo, Philip S. Low, Maie S. Taha, Wooin Lee, Joonyoung Park, Jiayin Shen, Venkatesh Chelvam, Christopher M. Fulkerson and Sagar M. Utturkar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nano Letters and Cancer Research.

In The Last Decade

Gregory M. Cresswell

15 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory M. Cresswell United States 9 121 114 83 77 74 17 348
Hye-Yeong Kim United States 11 94 0.8× 109 1.0× 65 0.8× 90 1.2× 71 1.0× 16 361
Suke Deng China 7 216 1.8× 147 1.3× 124 1.5× 90 1.2× 73 1.0× 11 409
Jinti Lin China 8 142 1.2× 170 1.5× 97 1.2× 72 0.9× 47 0.6× 10 375
Matthew Z. Madden United States 9 160 1.3× 172 1.5× 115 1.4× 35 0.5× 57 0.8× 12 394
Wenda Ye United States 7 92 0.8× 106 0.9× 117 1.4× 38 0.5× 65 0.9× 11 327
Aaron Dolor United States 7 114 0.9× 117 1.0× 80 1.0× 109 1.4× 18 0.2× 8 346
Dipakkumar R. Prajapati United States 8 147 1.2× 137 1.2× 167 2.0× 65 0.8× 25 0.3× 15 344
Dongbing Ding China 12 147 1.2× 210 1.8× 179 2.2× 140 1.8× 92 1.2× 20 509
Zhiwei Peng China 10 153 1.3× 72 0.6× 76 0.9× 50 0.6× 53 0.7× 32 338

Countries citing papers authored by Gregory M. Cresswell

Since Specialization
Citations

This map shows the geographic impact of Gregory M. Cresswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Cresswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Cresswell more than expected).

Fields of papers citing papers by Gregory M. Cresswell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory M. Cresswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Cresswell. The network helps show where Gregory M. Cresswell may publish in the future.

Co-authorship network of co-authors of Gregory M. Cresswell

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory M. Cresswell. A scholar is included among the top collaborators of Gregory M. Cresswell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory M. Cresswell. Gregory M. Cresswell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Fenghua, Md. Yusuf Al-Amin, Sagar M. Utturkar, et al.. (2025). Folate receptor β performs an immune checkpoint function in activated macrophages. Frontiers in Immunology. 16. 1638907–1638907.
2.
Lanman, Nadia A., Philip Fitchev, Gregory M. Cresswell, et al.. (2025). Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia. Frontiers in Immunology. 15. 1494476–1494476. 4 indexed citations
3.
Lanman, Nadia A., Renee E. Vickman, Gregory M. Cresswell, et al.. (2025). Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasia. Frontiers in Immunology. 16. 1585446–1585446.
4.
Zhang, Fenghua, Sagar M. Utturkar, Gregory M. Cresswell, et al.. (2024). Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment. Frontiers in Immunology. 15. 1354735–1354735. 5 indexed citations
5.
Keneally, Ryan J., Xiomara Fernandez, Gregory M. Cresswell, et al.. (2023). In Vitro Analysis of Platelet Adhesion, Aggregation, and Surface GP1bα Expression in Stored Refrigerated Whole Blood: A Pilot Study. Anesthesia & Analgesia. 136(5). 920–926. 3 indexed citations
6.
Morato, Nicolás M., Wen‐Hung Wang, Bennett D. Elzey, et al.. (2022). Changes in lipid profile and SOX-2 expression in RM-1 cells after co-culture with preimplantation embryos or with deproteinated blastocyst extracts. Molecular Omics. 18(6). 480–489. 1 indexed citations
7.
Chen, Hao, Gregory M. Cresswell, Sarah Libring, et al.. (2022). Tumor Cell–Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer. Cancer Research Communications. 2(10). 1104–1118. 6 indexed citations
8.
Meng, Fanfei, Jianping Wang, Gregory M. Cresswell, et al.. (2022). A single local delivery of paclitaxel and nucleic acids via an immunoactive polymer eliminates tumors and induces antitumor immunity. Proceedings of the National Academy of Sciences. 119(22). e2122595119–e2122595119. 24 indexed citations
9.
Akhand, Saeed Salehin, Ammara Abdullah, Hang Lin, et al.. (2020). Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade. Cancer Immunology Research. 8(12). 1542–1553. 26 indexed citations
10.
Cresswell, Gregory M., Bingbing Wang, Renee E. Vickman, et al.. (2020). Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs. Cancer Research. 81(3). 671–684. 56 indexed citations
11.
Yang, Yi, Emily White, Gregory M. Cresswell, et al.. (2020). Thrombin‐PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment. Journal of Thrombosis and Haemostasis. 19(1). 161–172. 27 indexed citations
12.
Knapp, Deborah W., Deepika Dhawan, José A. Ramos‐Vara, et al.. (2020). Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans. Frontiers in Oncology. 9. 1493–1493. 51 indexed citations
13.
Vickman, Renee E., Jiang Yang, Nadia A. Lanman, et al.. (2019). Cholesterol Sulfotransferase SULT2B1b Modulates Sensitivity to Death Receptor Ligand TNFα in Castration-Resistant Prostate Cancer. Molecular Cancer Research. 17(6). 1253–1263. 8 indexed citations
14.
Nikhil, Kumar, Keith Viccaro, Max Jacobsen, et al.. (2019). Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer. Cancer Letters. 448. 182–196. 29 indexed citations
15.
Taha, Maie S., Gregory M. Cresswell, Joonyoung Park, et al.. (2019). Sustained Delivery of Carfilzomib by Tannic Acid-Based Nanocapsules Helps Develop Antitumor Immunity. Nano Letters. 19(11). 8333–8341. 63 indexed citations
16.
Burcham, Grant N., Gregory M. Cresswell, Paul W. Snyder, et al.. (2014). Impact of Prostate Inflammation on Lesion Development in the POET3+ Pten Mouse Model of Prostate Carcinogenesis. American Journal Of Pathology. 184(12). 3176–3191. 9 indexed citations
17.
Shen, Jiayin, Venkatesh Chelvam, Gregory M. Cresswell, & Philip S. Low. (2013). Use of Folate-Conjugated Imaging Agents To Target Alternatively Activated Macrophages in a Murine Model of Asthma. Molecular Pharmaceutics. 10(5). 1918–1927. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026